Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk Assessment

被引:89
作者
Cheung, Connie [1 ]
Gonzalez, Frank J. [1 ]
机构
[1] Natl Canc Inst, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1124/jpet.108.141242
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450s (P450s) are important enzymes involved in the metabolism of xenobiotics, particularly clinically used drugs, and are also responsible for metabolic activation of chemical carcinogens and toxins. Many xenobiotics can activate nuclear receptors that in turn induce the expression of genes encoding xenobiotic metabolizing enzymes and drug transporters. Marked species differences in the expression and regulation of cytochromes P450 and xenobiotic nuclear receptors exist. Thus, obtaining reliable rodent models to accurately reflect human drug and carcinogen metabolism is severely limited. Humanized transgenic mice were developed in an effort to create more reliable in vivo systems to study and predict human responses to xenobiotics. Human P450s or human xenobiotic-activated nuclear receptors were introduced directly or replaced the corresponding mouse gene, thus creating "humanized" transgenic mice. Mice expressing human CYP1A1/CYP1A2, CYP2E1, CYP2D6, CYP3A4, CY3A7, pregnane X receptor, and peroxisome proliferator-activated receptor alpha were generated and characterized. These humanized mouse models offer a broad utility in the evaluation and prediction of toxicological risk that may aid in the development of safer drugs.
引用
收藏
页码:288 / 299
页数:12
相关论文
共 70 条
[41]   POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].
MAHGOUB, A ;
IDLE, JR ;
DRING, LG ;
LANCASTER, R ;
SMITH, RL .
LANCET, 1977, 2 (8038) :584-586
[42]   Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction [J].
Martignoni, Marcella ;
Groothuis, Geny M. M. ;
de Kanter, Ruben .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (06) :875-894
[43]  
Masubuchi Y, 1997, J PHARMACOL EXP THER, V282, P1435
[44]   Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage [J].
Morgan, K ;
French, SW ;
Morgan, TR .
HEPATOLOGY, 2002, 36 (01) :122-134
[45]   Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor α to Wy-14,643-induced liver tumorigenesis [J].
Morimura, K ;
Cheung, C ;
Ward, JM ;
Reddy, JK ;
Gonzalez, FJ .
CARCINOGENESIS, 2006, 27 (05) :1074-1080
[46]   Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism [J].
Muruganandan, S. ;
Sinal, C. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) :818-828
[47]   Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer [J].
Nebert, DW ;
Dalton, TP ;
Okey, AB ;
Gonzalez, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) :23847-23850
[48]   Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants [J].
Nelson, DR ;
Zeldin, DC ;
Hoffman, SMG ;
Maltais, LJ ;
Wain, HM ;
Nebert, DW .
PHARMACOGENETICS, 2004, 14 (01) :1-18
[49]   Peroxisome proliferator activated receptor-α expression in human liver [J].
Palmer, CNA ;
Hsu, MH ;
Griffin, KJ ;
Raucy, JL ;
Johnson, EF .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :14-22
[50]   Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 [J].
Peters, JM ;
Cattley, RC ;
Gonzalez, FJ .
CARCINOGENESIS, 1997, 18 (11) :2029-2033